ArticleLipids in health and disease2026
Joint effects of depression, lipid metabolic dysfunction, and their trajectories on incident cardiometabolic multimorbidity: a prospective multi-cohort analysis from two national cohorts.
Article in Lipids in health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundCardiometabolic multimorbidity (CMM) imposes a growing public health burden on middle-aged and older adults. Depression and lipid metabolic dysfunction are modifiable risk factors for CMM, yet their joint effects and dynamic co-trajectories on CMM risk across diverse ageing populations remain poorly understood.
methodsThis prospective multicohort study used individual-level data from the China Health and Retirement Longitudinal Study (CHARLS) and the English Longitudinal Study of Ageing (ELSA). Two analytical risk sets were defined to support static and dynamic analyses. Metabolic status was assessed using the atherogenic index of plasma (AIP) and remnant cholesterol (RC); depressive symptoms were measured by the Centre for Epidemiologic Studies Depression Scale (CES-D). Cox proportional hazards regression, counterfactual population attributable fractions (PAF), interaction analyses, and trajectory analyses were applied to examine associations between depression, metabolic status, and incident CMM. Multiple sensitivity analyses confirmed robustness.
resultsDepression and metabolic dysfunction each independently increased CMM risk, and their co-occurrence conferred the highest risk (AIP, fully adjusted: CHARLS HR = 1.71, 95% CI 1.45-2.01; ELSA HR = 1.55, 95% CI 1.26-1.89), with consistent findings for RC. In the dynamic analysis, persistent co-exposure to elevated metabolic burden and depression was associated with the greatest CMM risk in CHARLS (HR = 2.78, 95% CI 1.73-4.45), with a consistent directional pattern in ELSA.
conclusionsDepression and lipid metabolic dysfunction independently and jointly increase incident CMM risk across two nationally representative ageing cohorts. Integrating mental health screening and metabolic assessment into CMM primary prevention may offer meaningful reductions in disease burden across diverse ageing populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.